Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)

NCT00096460 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped lower than anticipated accrual

Conditions

Recurrent Grade 1 Follicular Lymphoma
Recurrent Grade 2 Follicular Lymphoma
Recurrent Grade 3 Follicular Lymphoma
Follicular Lymphoma

Interventions

DRUG: Cyclophosphamide and Rituximab
DRUG: Filgrastim
RADIATION: Chemotherapy or Radiation therapy
DRUG: Non-myeloablative Conditioning regimen
PROCEDURE: Allogeneic transplant
PROCEDURE: Autologous transplant
DRUG: Rituximab maintenance therapy
DRUG: GVHD Prophylaxis

Sponsor

Medical College of Wisconsin

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]